A retrospective study evaluating the pharmacokinetic properties of direct oral anticoagulants in patients with Atrial fibrillation and extreme obesity
Latest Information Update: 14 Aug 2021
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary)
- Indications Stroke; Thrombosis; Venous thromboembolism
- Focus Pharmacokinetics
- 14 Aug 2021 New trial record
- 05 Aug 2021 Results published in the Clinical Therapeutics